181 related articles for article (PubMed ID: 18004626)
1. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.
Morris KT; Busam KJ; Bero S; Patel A; Brady MS
Ann Surg Oncol; 2008 Jan; 15(1):316-22. PubMed ID: 18004626
[TBL] [Abstract][Full Text] [Related]
2. Role of sentinel lymph node biopsy in patients with thick (>4 mm) primary melanoma.
Jacobs IA; Chang CK; Salti GI
Am Surg; 2004 Jan; 70(1):59-62. PubMed ID: 14964550
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
5. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
6. Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary?
Elias N; Tanabe KK; Sober AJ; Gadd MA; Mihm MC; Goodspeed B; Cosimi AB
Arch Surg; 2004 Apr; 139(4):400-4; discussion 404-5. PubMed ID: 15078708
[TBL] [Abstract][Full Text] [Related]
7. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.
Kesmodel SB; Karakousis GC; Botbyl JD; Canter RJ; Lewis RT; Wahl PM; Terhune KP; Alavi A; Elder DE; Ming ME; Guerry D; Gimotty PA; Fraker DL; Czerniecki BJ; Spitz FR
Ann Surg Oncol; 2005 Jun; 12(6):449-58. PubMed ID: 15864482
[TBL] [Abstract][Full Text] [Related]
8. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy.
Zapas JL; Coley HC; Beam SL; Brown SD; Jablonski KA; Elias EG
J Am Coll Surg; 2003 Sep; 197(3):403-7. PubMed ID: 12946795
[TBL] [Abstract][Full Text] [Related]
9. [Sentinel lymph node biopsy in patients with cutaneous malignant melanoma].
Gad D; Sjøgren P
Ugeskr Laeger; 2003 Jun; 165(25):2567-70. PubMed ID: 12854268
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma.
Vuylsteke RJ; Borgstein PJ; van Leeuwen PA; Gietema HA; Molenkamp BG; Statius Muller MG; van Diest PJ; van der Sijp JR; Meijer S
Ann Surg Oncol; 2005 Jun; 12(6):440-8. PubMed ID: 15864481
[TBL] [Abstract][Full Text] [Related]
11. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma.
McMasters KM; Wong SL; Edwards MJ; Ross MI; Chao C; Noyes RD; Viar V; Cerrito PB; Reintgen DS
Surgery; 2001 Aug; 130(2):151-6. PubMed ID: 11490343
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of lymph mode recurrence in patients with melanoma and negative sentinel lymph node negative. Retrospective study at the Hospital Saint-Louis, Paris].
Derhy Y; Kerob D; Verola O; Binder JP; Lebbe C; Revol M; Servant JM
Ann Chir Plast Esthet; 2005 Apr; 50(2):104-12. PubMed ID: 15820595
[TBL] [Abstract][Full Text] [Related]
14. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system.
Wong SL; Kattan MW; McMasters KM; Coit DG
Ann Surg Oncol; 2005 Apr; 12(4):282-8. PubMed ID: 15827679
[TBL] [Abstract][Full Text] [Related]
15. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
[TBL] [Abstract][Full Text] [Related]
16. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy.
Yee VS; Thompson JF; McKinnon JG; Scolyer RA; Li LX; McCarthy WH; O'Brien CJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF
Ann Surg Oncol; 2005 Jun; 12(6):429-39. PubMed ID: 15886905
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in patients with thin melanoma.
Lowe JB; Hurst E; Moley JF; Cornelius LA
Arch Dermatol; 2003 May; 139(5):617-21. PubMed ID: 12756098
[TBL] [Abstract][Full Text] [Related]
18. Previous wide local excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk and extremity.
Leong WL; Ghazarian DM; McCready DR
J Surg Oncol; 2003 Mar; 82(3):143-6. PubMed ID: 12619055
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of malignant melanoma using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy: the Emory experience.
Murray DR; Carlson GW; Greenlee R; Alazraki N; Fry-Spray C; Hestley A; Poole R; Blais M; Timbert DS; Vansant J
Am Surg; 2000 Aug; 66(8):763-7. PubMed ID: 10966037
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic mapping and sentinel lymph node biopsy for malignant melanoma in Japanese.
Motomura H; Ishii M
Osaka City Med J; 2004 Jun; 50(1):29-37. PubMed ID: 15646256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
